| (USD) | Sep 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -2.16M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ANEB returned -87.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -67.3% |
| 1 year | -87.3% |
| 5 years | -95.1% |
| All-time high | $8.20 (May 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ANEB would be worth today ›No. Anebulo Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Anebulo Pharmaceuticals, Inc. is part of the Healthcare sector.
Anebulo Pharmaceuticals, Inc. has a market cap of 13.46M USD, based on the latest quote.